ALVR Market Cap History
Below is a table of the ALVR market cap history going back to 7/30/2020:

Date ALVR Market Cap

Also see: ALVR Shares Outstanding History
and ALVR YTD Return
ALVR Historical Market Cap:
-1.25% CAGR
ALVR Historical Market Cap: +-1.25% CAGR

Mouse over chart for data details
AlloVir is a late clinical-stage cell therapy company developing allogeneic T-cell therapies to treat and prevent viral diseases. Co.'s key product candidate, Viralym-M, is a multi-VST therapy targeting five viruses: BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. ALVR106 is Co.'s second multi-virus-targeted off-the-shelf VST product candidate that it developed to target respiratory diseases. ALVR109 is an allogeneic, off-the-shelf single virus-targeted cell therapy designed to target SARS-CoV-2. Co. is also developing ALVR107 designed to target hepatitis B, or HBV, infected cells and treat chronic HBV infections and ALVR108 to treat human herpesvirus-8. We show 5 historical shares outstanding datapoints in our ALVR shares outstanding history coverage, used to compute ALVR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALVR market cap history over the course of time is important for investors interested in comparing ALVR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALVR versus a peer is one thing; comparing ALVR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALVR can fluctuate over the course of history. With this page we aim to empower investors researching ALVR by allowing them to research the ALVR market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ALVR:
ALVR SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AlloVir (ALVR) is categorized under the Technology sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AMAT Market Cap History
AMBA Market Cap History
AMBR Market Cap History
AMD Market Cap History
AMKR Market Cap History
AMRH Market Cap History
ANET Market Cap History
ANGI Market Cap History
ANSS Market Cap History
AOSL Market Cap History
More Technology companies »


ALVR Market Cap History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.